CSF2 and breast carcinoma: The remainder of this review will focus on the factors identified by EMT manipulation (CD73, HO-1, TDO2, GM-CSF, M-CSF, CHI3L1 and OPN) and will highlight preclinical and clinical studies that demonstrate how each impact breast cancer metastasis and immune suppression (summarized in Figure 2).